UNGRODT JODI exercised Options for 5,647 BioStem Technologies shares at $0 on 2026-08-27. The transaction left JODI with 11,295 BioStem shares and zero derivative securities, giving investors a clear view of the resulting ownership position and the recorded cost of the exercise.
Key Highlights
- JODI owned 11,295 BioStem Technologies shares after the transaction.
- The post-transaction record showed zero derivative securities.
- The transaction was marked with SEC code M on 2026-08-27.
The transaction concerns JODI’s position as an insider of BioStem Technologies. The post-transaction ownership record lists the resulting holdings in both shares and derivative securities.
BioStem Option Exercise Leaves 11,295 Shares
JODI’s transaction covered 5,647 BioStem Technologies shares. The exercise price was recorded as $0. The transaction date was 2026-08-27, and the entry carried SEC transaction code M.
The post-transaction record showed zero derivative securities. The ownership figures therefore distinguish the shares held after the exercise from the derivative securities position recorded at the same point.
FAQs
Q: What did UNGRODT JODI exercise in BioStem Technologies?
A: JODI exercised options for 5,647 BioStem Technologies shares at $0 on 2026-08-27. The transaction carried SEC code M.
Q: How many BioStem shares did UNGRODT JODI own afterward?
A: After the option exercise, JODI owned 11,295 BioStem Technologies shares. The post-transaction record also showed zero derivative securities.
Q: Did JODI retain derivative securities after the exercise?
A: The post-transaction ownership record showed zero derivative securities for JODI. It separately listed 11,295 BioStem Technologies shares following the exercise.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.